Covid-19 vaccination: cancer patients are a priority


The National Cancer Institute is advocating for an “immediate” vaccination against Covid-19 for patients 16 years of age and over suffering from hematologic malignancies and solid cancers.

Myeloma, lymphoma, leukemia …: here are the comorbidities which should soon give priority to a vaccination

Should patients with cancer be vaccinated as a priority against Covid-19, on the same basis as the elderly? Yes, answers the National Cancer Institute, which has just transmitted its recommendations to Professor Alain Fischer, chairman of the advisory board for the vaccine strategy. According to these recommendations, among patients with hematologic malignancies, patients who have received an allogeneic hematopoietic stem cell transplant, more than 3 months and less than 3 years from their allogeneic transplant, should be considered as “high priority”.

Priority should also be given to actively treated patients (including maintenance treatments) for acute hemopathy, regardless of its type (myeloid or lymphoid) and regardless of their age if their treatment program is not carried out. mostly in prolonged hospitalization; patients actively treated for multiple myeloma, T lymphoma, diffuse large B-cell lymphoma, follicular lymphoma, chronic lymphoid leukemia, as first and second line treatment for these pathologies as well as patients for whom one of these pathologies have just been diagnosed and which must be placed in the short term in active treatment.

Cancer, one comorbidity among others to be a priority for vaccination

Among the patients with solid cancers, patients under active treatment, without curative aim, by first or second line chemotherapy, and patients receiving radiotherapy for a primary intrathoracic tumor including a pulmonary volume, are considered as “high priority”. Importantly, radiotherapy including a large number of thoracic and / or abdomino-pelvic lymph node areas and / or a large volume of hematopoietic tissue and patients whose treatment for their neoplasia is undertaken with a curative aim.

These categories of patients are not yet eligible for priority vaccination: for the moment and at this stage, among cancer patients, the vaccination strategy, as formulated by the High Authority for Health, only retains cancer carriers. recent less than three years old. This recommendation from the National Cancer Institute therefore aims to specify and expand the range of patients eligible for vaccination as a priority.

As a reminder, in the same way as people with cancer, the High Authority for Health considers people suffering from obesity (BMI> 30) as a priority for vaccination, in particular among the youngest, COPD and respiratory failure, complicated high blood pressure. , heart failure, types 1 and 2 diabetes, chronic renal failure, recent cancers less than three years old, organ and stem cell transplant recipients and people with Down’s syndrome.